Quadrant Capital Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-969
| Closed | -$17.3K | – | 2174 |
|
|
2025
Q1 | $17.3K | Sell |
969
-526
| -35% | -$9.37K | ﹤0.01% | 2076 |
|
|
2024
Q4 | $44.6K | Buy |
1,495
+296
| +25% | +$8.82K | ﹤0.01% | 1485 |
|
|
2024
Q3 | $18.7K | Sell |
1,199
-246
| -17% | -$3.85K | ﹤0.01% | 1921 |
|
|
2024
Q2 | $24.8K | Buy |
1,445
+1,112
| +334% | +$19K | ﹤0.01% | 1757 |
|
|
2024
Q1 | $5.21K | Buy |
333
+117
| +54% | +$1.83K | ﹤0.01% | 2305 |
|
|
2023
Q4 | $3.23K | Buy |
216
+68
| +46% | +$1.02K | ﹤0.01% | 2374 |
|
|
2023
Q3 | $2.39K | Buy |
148
+100
| +208% | +$1.62K | ﹤0.01% | 2345 |
|
|
2023
Q2 | $1.99K | Sell |
48
-138
| -74% | -$5.73K | ﹤0.01% | 2415 |
|
|
2023
Q1 | $11.2K | Sell |
186
-81
| -30% | -$4.87K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $19.6K | Sell |
267
-127
| -32% | -$9.32K | ﹤0.01% | 1668 |
|
|
2022
Q3 | $30K | Sell |
394
-56
| -12% | -$4.26K | ﹤0.01% | 1323 |
|
|
2022
Q2 | $31K | Sell |
450
-151
| -25% | -$10.4K | ﹤0.01% | 1084 |
|
|
2022
Q1 | $50K | Buy |
601
+383
| +176% | +$31.9K | 0.01% | 922 |
|
|
2021
Q4 | $16K | Buy |
218
+167
| +327% | +$12.3K | ﹤0.01% | 1406 |
|
|
2021
Q3 | $6K | Sell |
51
-96
| -65% | -$11.3K | ﹤0.01% | 1813 |
|
|
2021
Q2 | $33K | Buy |
147
+75
| +104% | +$16.8K | ﹤0.01% | 1001 |
|
|
2021
Q1 | $10K | Buy |
72
+65
| +929% | +$9.03K | ﹤0.01% | 1502 |
|
|
2020
Q4 | $1K | Buy |
7
+3
| +75% | +$429 | ﹤0.01% | 2161 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 2260 |
|
|
2019
Q4 | – | Sell |
-76
| Closed | -$5K | – | 2467 |
|
|
2019
Q3 | $5K | Buy |
+76
| New | +$5K | ﹤0.01% | 1924 |
|